Report Library
All ReportsDatamonitor Epilepsy KOL Interviews
October 06, 2016
Datamonitor interviewed two epilepsy specialists, one based in the US and the other based in the UK, to determine their views on the
disease segmentation, clinical trial design, and on some of the marketed and pipeline drugs. The two interviews were combined
into a single report.
If you are a KOL Insight Subscriber, please access the first and second interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
If you are a KOL Insight Subscriber, please access the first and second interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: |
Dravet Syndrome (Epilepsy)
Infantile Spasms (West Syndrome; Epilepsy) Lennox-Gastaut Syndrome (LGS; Epilepsy) Partial / Focal Seizures (Epilepsy) Seizure Disorders (Epilepsy) Tuberous Sclerosis Complex (TSC) |